151 related articles for article (PubMed ID: 1333336)
1. Results of the surveillance policy of stage I non-seminomatous germ cell testicular tumours.
Colls BM; Harvey VJ; Skelton L; Thompson PI; Dady PJ; Forgeson GV; Perez DJ
Br J Urol; 1992 Oct; 70(4):423-8. PubMed ID: 1333336
[TBL] [Abstract][Full Text] [Related]
2. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer.
Studer UE; Fey MF; Calderoni A; Kraft R; Mazzucchelli L; Sonntag RW
Eur Urol; 1993; 23(4):444-9. PubMed ID: 7687549
[TBL] [Abstract][Full Text] [Related]
4. Orchiectomy alone for Stage I testicular non-seminoma. A progress report on the Royal Marsden Hospital study.
Peckham MJ; Barrett A; Horwich A; Hendry WF
Br J Urol; 1983 Dec; 55(6):754-9. PubMed ID: 6317135
[TBL] [Abstract][Full Text] [Related]
5. Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis.
Pizzocaro G; Zanoni F; Salvioni R; Milani A; Piva L; Pilotti S
J Urol; 1987 Dec; 138(6):1393-6. PubMed ID: 2824862
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
Divrik RT; Akdoğan B; Ozen H; Zorlu F
J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
[TBL] [Abstract][Full Text] [Related]
7. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
8. [Clinical presentation of testicular germinal cancer].
Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
[TBL] [Abstract][Full Text] [Related]
9. Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse.
Alexandre J; Fizazi K; Mahé C; Culine S; Droz JP; Théodore C; Terrier-Lacombe MJ
Eur J Cancer; 2001 Mar; 37(5):576-82. PubMed ID: 11290432
[TBL] [Abstract][Full Text] [Related]
10. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
Schmidt P; Haas RJ; Göbel U; Calaminus G
Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Risk-adapted Surveillance vs Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: A Retrospective Follow-up Study of 81 Patients.
Fan G; Zhang L; Yi L; Jiang ZQ; Ke Y; Wang XS; Xiong YY; Han WQ; Zhou X; Liu C; Yu X
Asian Pac J Cancer Prev; 2015; 16(8):3267-72. PubMed ID: 25921130
[TBL] [Abstract][Full Text] [Related]
12. Multicentre risk-adapted management for stage I non-seminomatous germ cell tumours.
Maroto P; García del Muro X; Aparicio J; Paz-Ares L; Arranz JA; Guma J; Terrassa J; Barnadas J; Dorta J; Germà-Lluch JR
Ann Oncol; 2005 Dec; 16(12):1915-20. PubMed ID: 16126737
[TBL] [Abstract][Full Text] [Related]
13. Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres.
Ernst DS; Brasher P; Venner PM; Czaykowski P; Moore MJ; Reyno L; Winquist E; Segal R; Hao D
Can J Urol; 2005 Apr; 12(2):2575-80. PubMed ID: 15877938
[TBL] [Abstract][Full Text] [Related]
14. Late results of surveillance of clinical stage I nonseminoma germ cell testicular tumours: 17 years' experience in a national study in New Zealand.
Colls BM; Harvey VJ; Skelton L; Frampton CM; Thompson PI; Bennett M; Perez DJ; Dady PJ; Forgeson GV; Kennedy IC
BJU Int; 1999 Jan; 83(1):76-82. PubMed ID: 10233456
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcome in patients with stage-I nonseminomatous germ cell cancer. A critical review of own treatment modalities in a retrospective study.
Seseke S; Bierwirth S; Strauss A; Ringert RH; Seseke F
Int Braz J Urol; 2008; 34(6):715-22; discussion 723-4. PubMed ID: 19111076
[TBL] [Abstract][Full Text] [Related]
16. Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours.
Peckham MJ; Barrett A; Husband JE; Hendry WF
Lancet; 1982 Sep; 2(8300):678-80. PubMed ID: 6126625
[TBL] [Abstract][Full Text] [Related]
17. Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer. Danish Testicular Cancer Study Group.
Rørth M; Jacobsen GK; von der Maase H; Madsen EL; Nielsen OS; Pedersen M; Schultz H
J Clin Oncol; 1991 Sep; 9(9):1543-8. PubMed ID: 1714948
[TBL] [Abstract][Full Text] [Related]
18. Surveillance following orchidectomy for stage I testicular cancer.
Peckham MJ; Brada M
Int J Androl; 1987 Feb; 10(1):247-54. PubMed ID: 3034794
[TBL] [Abstract][Full Text] [Related]
19. Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology.
Nolan L; Wheater M; Kirby J; Simmonds P; Mead G
BJU Int; 2010 Dec; 106(11):1648-51. PubMed ID: 20735393
[TBL] [Abstract][Full Text] [Related]
20. Surveillance or lymph node dissection in clinical stage I non-seminomatous germinal testis cancer?
Pizzocaro G; Zanoni F; Salvioni R; Milani A; Piva L
Br J Urol; 1985 Dec; 57(6):759-62. PubMed ID: 3002535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
